Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine
- Status
- COMPLETED
- Phase
- NA
In-Vivo Activated T-Cell Depletion to Prevent GVHD
- Status
- TERMINATED
- Phase
- NA
Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)
- Status
- COMPLETED
- Phase
- PHASE3
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE1
Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Matched Unrelated or Non-Genotype Identical Related Donor Transplantation For Chronic Granulomatous Disease
- Status
- COMPLETED
- Phase
- PHASE2
T-Reg Cell Kinetics, Stem Cell Transplant, REGALE
- Status
- TERMINATED
- Phase
- NA
T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE
- Status
- TERMINATED
- Phase
- NA
Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO
- Status
- TERMINATED
- Phase
- NA
Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2